Breaking News
Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and regulatory obligations. To learn more, please visit www.pfizer.com.
Prevnar

Health Care Professionals Log In

 

Important Safety Information

In clinical trials (n=18,168), the most frequently reported adverse events included injection site reactions, fever
(≥ 38ºC/100.4ºF), irritability, drowsiness, restless sleep, decreased appetite, vomiting, diarrhea, and rash.

Risks are associated with all vaccines, including Prevnar®. Hypersensitivity to any vaccine component, including diphtheria toxoid, is a contraindication to its use. Prevnar® does not provide 100% protection against vaccine serotypes or protect against nonvaccine serotypes.

Please see Prescribing Information.

References:

  1. Prevnar®, Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein), Prescribing Information,
    Wyeth Pharmaceuticals Inc.
  2. Centers for Disease Control and Prevention. Recommended childhood and adolescent immunization schedule-United States, 2008. MMWR. 2008;57(01):Q1-Q4.